A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196.
about
A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A phase I study of foretinib p ...... n cancer trials group IND.196.
@en
A phase I study of foretinib p ...... n cancer trials group IND.196.
@nl
type
label
A phase I study of foretinib p ...... n cancer trials group IND.196.
@en
A phase I study of foretinib p ...... n cancer trials group IND.196.
@nl
prefLabel
A phase I study of foretinib p ...... n cancer trials group IND.196.
@en
A phase I study of foretinib p ...... n cancer trials group IND.196.
@nl
P2093
P2860
P356
P1433
P1476
A phase I study of foretinib p ...... n cancer trials group IND.196.
@en
P2093
Dongsheng Tu
Frances A Shepherd
Garth Nicholas
Glenwood Goss
Jean Powers
John R Goffin
Lesley Seymour
Natasha B Leighl
P2860
P304
69651-69662
P356
10.18632/ONCOTARGET.18753
P407
P577
2017-06-28T00:00:00Z